The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis

Journal of Medical Genetics

Volumn 41, Issue 12, 2004, Pages 946-950

  Valenti, L ^a   Conte, D ^a   Piperno, A ^b   Dongiovanni, P ^a   Fracanzani, A L ^a   Fraquelli, M ^a   Vergani, A ^c   Gianni, C ^d   Carmagnola, L ^a   Fargion, S ^a,e  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c Ospedale San Luca   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; SUPEROXIDE DISMUTASE;

ADULT; AGED; ALCOHOL ABUSE; ALLELE; ARTICLE; CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENE SEQUENCE; GENETIC RISK; GENOTYPE; HEART DISEASE; HEMOCHROMATOSIS; HUMAN; HYPOGONADISM; IRON OVERLOAD; ISCHEMIC HEART DISEASE; KNOCKOUT MOUSE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MITOCHONDRION; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; RESTRICTION MAPPING;

CARDIOMYOPATHIES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; HEMOCHROMATOSIS; HUMANS; ITALY; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREVALENCE; RISK FACTORS; SUPEROXIDE DISMUTASE;

EID: 19944401844     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2004.019588     Document Type: Article

References (34)

1. Harrison SA, Bacon BR. Hereditary hemochromatosis: update for 2003. J Hepatol 2003;38(Suppl 1):14-23.
2. Powell LW, Summers KM, Board PG, Axelsen E, Webb S, Halliday JW. Expression of hemochromatosis in homozygous subjects. Implication for early diagnosis and prevention. Gastroenterology 1990;98:1625-32.
3. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Wolff RK, et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996;13:399-408.
4. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341:718-24.
5. Beutler E, Felitti VJ, Kozial JA, Ho NJ, Gelbart T. Low penetrance of the 845G→A (C282Y) HFE hereditary hemochromatosis mutation. Lancet 2001;359:211-18.
6. Cox T, Rochette J, Camaschella C, Walker A, Robson K. Clinical hemochromatosis in HFE mutation carriers. Lancet 2002;360:412.
7. McCune A, Worwood M. Penetrance in hereditary hemochromatosis. Blood 2003;102:2696.
8. Lee PL, Gelbart T, West C, Halloran C, Felitti V, Beutler E. A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferropartin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin. Blood Cells Mol Dis 2001;27:783-802.
9. Beutler E, Gelbart T. Tumor necrosis factor alpha promoter palymorphisms and liver abnormalities of homozygotes for the 845G→A (C282Y) hereditary hemochromatosis mutation. Blood 2002;100:2268-2269.
10. Fargion S, Valenti L, Dongiovanni P, Scaccabarozzi A, Fracanzani AL, Taioli E, Mattioli M, Sampietro M, Fiorelli G. Tumor necrosis factor alpha promoter palymorphisms influence the phenotypic expression of hereditary hemochromatosis. Blood 2001;97:3707-12.
11. Pietrangelo A. Iron oxidative stress and liver fibrogenesis. J Hepatol 1998;28(Suppl 1):8-13.
12. Niemela O, Parkkila S, Britton RS, Brunt E, Janney C, Bacon BR. Hepatic lipid peroxidation in hereditary hemochromatosis and alcoholic liver injury. J Lab Clin Med 1999;133:451-60.
13. Perez MJ, Cederbaum Al. Adenovirus mediated expression of Cu/Zn- or Mn-superoxide dismutase protects against CYP2E1-dependent toxicity. Hepatology 2003;38:1146-58.
14. Wheeler MD, Nakagami M, Bradford BU, Uesugi T, Mason RP, Connor HD, Dikalova A, Kadiiska M, Thurman RG. Overexpression of manganese superoxide dismutase prevents alcohol induced liver injury in the rat. J Biol Chem 2001;276:36664-72.
15. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble U, Yoshimura MP, Berger C, Chan PH. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 1995;11:376-81.
16. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Attori Y, Shimizu Y, Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. Biochem Biophys Res Commun 1996;226:561-5.
17. Degoul F, Sutton A, Mansouri A, Cepanec C, Degott C, Fromenty B, Beaugrand M, Valla D, Pessayre D. Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease. Gastroenterology 2001;120:1468-74.
18. Sutton A, Khoury H, Prip-Buus C, Cepanec C, Pessayre D, Degoul F. The Ala 16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 2003;13:145-57.
19. Fracanzoni AL, Conte D, Fraquelli M, Taioli E, Mattioli M, Losco A, Fargion S. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non iron-related chronic liver disease. Hepatology 2001;33:647-51.
20. Barry M, Sherlock S. Measurement of liver iron concentration in needle biopsy specimens. Lancet 1971;1:100-3.
21. Sinigaglia L, Fargion S, Fracanzani AL, Binelli L, Battafarano N, Varenna M, Piperno A, Fiorelli G. Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload. J Rheumatol 1997;24:1809-13.
22. Cecchetti G, Binda A, Piperno A, Nador F, Fargion S, Fiorelli G. Cardiac alterations in 36 consecutive patients with idiopathic haemochromatosis: polygraphic and echocardiographic evaluation. Eur Heart J 1991;12:224-30.
23. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996;93:841-2.
24. Muhlestein JB. Cardiac abnormalities in hemochromatosis. In: Barton JC, Edwards CQ, eds. Hemochromatosis: genetic, pathophysiology, diagnosis and treatment. Cambridge, UK: Cambridge University Press, 2000:297-311.
25. Camoschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M, Majorano N, Totaro A, Gasparini P. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000;25:14-15.
26. Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, Trenor CC, Gasparini P, Andrews NC, Pietrangelo A. Autosomal-dominant hemochromatosis is associated with a mutation in the ferropartin (SLC11A3) gene. J Clin Invest 2001;108:619-23.
27. Piperno A, Sampietro M, Pietrangelo A, Arosio C, Lupica L, Montosi G, Vergani A, Fraquelli M, Girelli D, Pasquero P, Roetto A, Gasparini P, Fargion S, Conte D, Camaschella C. Heterogeneity of hemochromatosis in Italy. Gastroenterology 1998;114:996-1002.
28. Livesey KJ, Wimhurst VL, Carter K, Worwood M, Cadet E, Rochette J, Roberts AG, Pointon JJ, Merryweather-Clarke AT, Bassett ML, Jouanolle AM, Mosser A, David V, Poulton J, Robson KJ. The 16189 variant of mitochondrial DNA occurs more frequently in C282Y homozygotes with haemochromatosis than those without iron loading. J Med Genet 2004;41:6-10.
29. Pereira AC, Cuoco MAR, Mota GF, da Silva F, Freitas HFG, Bocchi EA, Soler JMP, Mansur AJ, Krieger JE. Hemochromatosis gene variants in patients with cardiomyopathy. Am J Cardiol 2001;88:388-91.
30. Hetet G, Elbaz A, Gariepy J, Nicaud V, Arveiler D, Morrison C, Kee F, Evans A, Simon A, Amarenco P, Cambien F, Grandchamp B. Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases. Eur J Clin Invest 2001;31:382-8.
31. Turoczi T, Jun L, Cordis G, Morris JE, Maulik N, Stevens RG, Das DK. HFE mutation and dietary iron content interact to increase ischemia/reperfusion injury of the heart in mice. Circ Res 2003;92:1240-6.
32. Hiroi S, Harada H, Nishi H, Sato N, Nagai R, Kimura A. Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese. Biochem Biophys Res Commun 1999;261:332-9.
33. Miranda CJ, Makui H, Soares RJ, Bilodeau M, Mui J, Vali H, Bertrand R, Andrews NC, Santos MM. Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin. Blood 2003;102:2574-80.
34. Hsiu-Chuan Y, Oberley TD, Vichitbandha S, Ho YS, St Clair DK. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest 1996;98:1253-60.